Who is leaving the Board of Directors?

Elizabeth A. Sanders, a member of the Board of Directors of WellPoint, Inc. (Elevance Health), has announced her intention to retire.

When will this director's retirement be effective?

The retirement will be effective as of the date of WellPoint, Inc.'s upcoming 2005 Annual Meeting of Shareholders.

What is the significance of this 8-K filing for investors?

This 8-K filing informs investors of a change in the company's board composition. While a single director's retirement is often routine, investors may want to track subsequent filings to understand how the board will be reconstituted and if new directors bring new expertise or strategic perspectives.

Does this filing indicate any financial or operational issues at Elevance Health?

No, this specific 8-K filing only reports the impending retirement of a board member. It does not contain information related to financial performance, operational changes, or strategic direction that would indicate immediate financial or operational issues.

ELV 8-K: Leadership Changes

Summary

Elevance Health, Inc. (operating as WellPoint, Inc. at the time of this filing) announced on January 5, 2005, that a member of its Board of Directors, Elizabeth A. Sanders, has notified the company of her intention to retire. Her retirement is scheduled to take effect at the Corporation's upcoming 2005 Annual Meeting of Shareholders. This filing is an 8-K, indicating a material event that could affect investor decisions. While the departure of a single board member is generally routine, investors should monitor future filings for any changes in board composition or governance structure that may arise from this retirement.

Key Highlights

1Elizabeth A. Sanders, a Director on the WellPoint, Inc. Board, has announced her intention to retire.
2Ms. Sanders' retirement is effective as of the 2005 Annual Meeting of Shareholders.
3This information was filed with the SEC on January 6, 2005, via an 8-K filing.
4The filing pertains to Item 5.02(b) regarding the departure of directors.
5No immediate strategic or financial implications are detailed in this specific filing.
6The filing was signed by David R. Frick, Executive Vice President and Chief Legal and Administrative Officer.

Elevance Health, Inc. 8-K Report, Executive Changes (Jan 6, 2005)

Summary

Key Highlights

Frequently Asked Questions